TG Therapeutics Inc (FRA:NKB2)
€ 51 +0.80 (+1.59%) Market Cap: 7.68 Bil Enterprise Value: 7.89 Bil PE Ratio: 19.97 PB Ratio: 15.00 GF Score: 81/100

TG Therapeutics Inc (FRA:NKB2) Transcripts

  • 1